MOG and experimental autoimmune encephalomyelitis: JQ1 was shown to have a beneficial effect on the severity of the classical, Th17‐dependent and non‐B‐dependent experimental autoimmune encephalomyelitis (EAE) induced with the immunodominant peptide of myelin oligodendrocyte glycoprotein (MOG).17